Shinda Biotech: The product revenue in 2025 is expected to be approximately 11.9 billion yuan, representing a year-on-year increase of about 45%.

Xinda Biotech announced that in the full year of 2025, the company achieved a total product revenue of approximately RMB 11.9 billion, maintaining a strong growth momentum of about 45% year-on-year. In the fourth quarter of 2025, the company achieved a total product revenue of approximately RMB 3.3 billion, a year-on-year increase of over 60%.